We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Not elementary

18 February 2016 By Robert Cyran

Big Blue’s market value rose by about $6 bln after it agreed to buy a healthcare analytics firm for $2.6 bln. Giving IBM’s artificial-intelligence platform more data to chew on is useful, but investors’ glee over an opaque addition to an enigmatic business effort is confusing.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)